Kensington Investment Counsel’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,293
Closed -$429K 104
2025
Q4
$429K Sell
7,293
-7,309
-50% -$444K 0.17% 90
2025
Q3
$812K Sell
14,602
-1,212
-8% -$64.9K 0.33% 72
2025
Q2
$814K Sell
15,814
-145
-0.9% -$7.29K 0.35% 69
2025
Q1
$936K Sell
15,959
-329
-2% -$22.3K 0.42% 64
2024
Q4
$1.17M Sell
16,288
-572
-3% -$42K 0.49% 63
2024
Q3
$1.35M Buy
16,860
+217
+1% +$16.3K 0.56% 58
2024
Q2
$1.19M Sell
16,643
-502
-3% -$36.9K 0.53% 59
2024
Q1
$1.21M Buy
17,145
+3,055
+22% +$219K 0.55% 60
2023
Q4
$1.09M Buy
14,090
+40
+0.3% +$2.63K 0.57% 61
2023
Q3
$956K Buy
14,050
+494
+4% +$39K 0.59% 60
2023
Q2
$1.11M Sell
13,556
-44
-0.3% -$3.54K 0.7% 53
2023
Q1
$1.01M Sell
13,600
-1,264
-9% -$97.4K 0.76% 51
2022
Q4
$1.23M Hold
14,864
0.97% 47
2022
Q3
$1.05M Buy
14,864
+5,560
+60% +$480K 0.89% 53
2022
Q2
$806K Sell
9,304
-148
-2% -$13.9K 0.69% 63
2022
Q1
$1.02M Sell
9,452
-9,932
-51% -$1.02M 0.68% 68
2021
Q4
$2.51M Buy
+19,384
New +$2.38M 1.46% 21
2021
Q2
$1.89M Buy
16,796
+416
+3% +$43.8K 1.3% 30
2021
Q1
$1.56M Buy
16,380
+1,296
+9% +$118K 1.18% 37
2020
Q4
$1.2M Buy
+15,084
New +$1.09M 0.99% 51

Other funds holding TECH

Kensington Investment Counsel's TECH Position: Q1 2026 in Review

Kensington Investment Counsel sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 7,293 shares — an estimated $429K sold.

Kensington Investment Counsel first reported a position in TECH in Q4 2020 and held it in 20 quarters. The position peaked at $2.51M in Q4 2021. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Kensington Investment Counsel reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Kensington Investment Counsel sold 7,293 Bio-Techne shares in Q1 2026, an estimated $429K.
  • Kensington Investment Counsel first reported a position in Bio-Techne in Q4 2020 and held it in 20 quarters.
  • Kensington Investment Counsel's Bio-Techne position peaked at $2.51M in Q4 2021.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.